GLPG Competitors & Alternatives
Compare Galapagos NV ADR with similar stocks in the same industry
Biotechnology
GLPG
Main Stock$27.73
Tradestie Score
59
Market Cap
$2.31B
P/E Ratio
5.1
Revenue Growth
10.9%
Analyst Upside
+3.0%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.47
|
$2.08B | - | 49 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.88
|
$2.02B | 44.5 | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.77
|
$2.01B | - | 50 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$38.86
|
$1.97B | - | 57 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$8.40
|
$1.92B | - | 58 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$87.72
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$83.85
|
$1.90B | 510.6 | 56 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$32.23
|
$1.84B | - | 47 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.43
|
$1.81B | - | 51 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.83
|
$1.78B | - | 55 | Compare |
More GLPG Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry